These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8540883)

  • 41. Fatal neuroleptic malignant syndrome in a previously long-term user of clozapine following its reintroduction in combination with paroxetine.
    Gambassi G; Capurso S; Tarsitani P; Liperoti R; Bernabei R
    Aging Clin Exp Res; 2006 Jun; 18(3):266-70. PubMed ID: 16804375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful clozapine rechallenge following prior intolerance to clozapine.
    Cohen SA
    J Clin Psychiatry; 1994 Nov; 55(11):498-9. PubMed ID: 7989287
    [No Abstract]   [Full Text] [Related]  

  • 43. Successful treatment of a complicated case of neuroleptic malignant syndrome.
    Lappa A; Podestà M; Capelli O; Castagna A; Di Placido G; Alampi D; Semeraro F
    Intensive Care Med; 2002 Jul; 28(7):976-7. PubMed ID: 12122539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Confusion, Rigidity, and Elevated Creatine Phosphokinase: Atypical Neuroleptic Malignant Syndrome Possibly Associated With Clozapine and Sodium Valproate Use.
    Uvais NA; Moideen S; Anver PC
    Prim Care Companion CNS Disord; 2022 Sep; 24(5):. PubMed ID: 36179364
    [No Abstract]   [Full Text] [Related]  

  • 45. Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature.
    Karagianis JL; Phillips LC; Hogan KP; LeDrew KK
    Ann Pharmacother; 1999 May; 33(5):623-30. PubMed ID: 10369628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protracted neuroleptic malignant syndrome complicating long-acting neuroleptic administration.
    Legras A; Hurel D; Dabrowski G; Grenet D; Graveleau P; Loirat P
    Am J Med; 1988 Dec; 85(6):875-8. PubMed ID: 2904226
    [No Abstract]   [Full Text] [Related]  

  • 47. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. It's a typical case of clozapine toxicity.
    Anand S
    Aust N Z J Psychiatry; 2012 Oct; 46(10):1008. PubMed ID: 23028199
    [No Abstract]   [Full Text] [Related]  

  • 49. Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'.
    Weller M; Kornhuber J
    Br J Psychiatry; 1992 Dec; 161():855-6. PubMed ID: 1362370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early introduction of clozapine after neuroleptic malignant syndrome may prevent malignant catatonia: A case report.
    van Rooijen G; Strypet M; Maat A; Scheepens DS; Oudijn MS; Klopper KE; Denys D
    Eur Neuropsychopharmacol; 2017 Jan; 27(1):91-92. PubMed ID: 27939254
    [No Abstract]   [Full Text] [Related]  

  • 51. Clozapine-induced neuroleptic malignant syndrome.
    DasGupta K; Young A
    J Clin Psychiatry; 1991 Mar; 52(3):105-7. PubMed ID: 2005072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Severe acute pancreatitis, neuroleptic malignant syndrome and grand mal seizures associated with elevated amisulpride and low clozapine serum levels.
    Bonnet U; Taazimi B; Montag M; Ronge R; Gespers H; Kuhlmann R; Grabbe D; Jahn J
    Psychiatr Danub; 2015 Dec; 27(4):424-5. PubMed ID: 26609657
    [No Abstract]   [Full Text] [Related]  

  • 53. Neuroleptic malignant syndrome associated with clozapine use.
    Anderson ES; Powers PS
    J Clin Psychiatry; 1991 Mar; 52(3):102-4. PubMed ID: 2005071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistent amnesia as a sequel of olanzapine-induced neuroleptic malignant syndrome.
    Mendhekar DN; Duggal HS
    J Neuropsychiatry Clin Neurosci; 2006; 18(4):552-3. PubMed ID: 17135384
    [No Abstract]   [Full Text] [Related]  

  • 55. [Case of malignant neuroleptic syndrome caused by an anti-depressive agent, later complicated by respiratory insufficiency and DIC].
    Okamoto K; Umeno M; Takagi H; Nagano S; Takeda Y
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):727-9. PubMed ID: 9627481
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].
    Weller M; Kornhuber J
    Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
    Rock W; Elias M; Lev A; Saliba WR
    Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroleptic rechallenge after neuroleptic malignant syndrome.
    Giacardi-Paty M; Bottai T; Pujalte D; Lainey E; Petit P
    Br J Psychiatry; 1993 Jul; 163():121-2. PubMed ID: 8102585
    [No Abstract]   [Full Text] [Related]  

  • 59. Apparent neuroleptic malignant syndrome with clozapine and lithium.
    Pope HG; Cole JO; Choras PT; Fulwiler CE
    J Nerv Ment Dis; 1986 Aug; 174(8):493-5. PubMed ID: 3090198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nothing new under the sun: clozapine rechallenge following a life-threatening medical event in a patient with psychiatric illness and developmental disability.
    Shedlack KJ; Levesque C; Charlot L; Bolduc M; Silka VR; Mikkelsen EJ; Cole JO
    Harv Rev Psychiatry; 2003; 11(6):344-52. PubMed ID: 14713570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.